Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Prevalence of venous thromboembolism in patients with chronic liver disease: A Turgut Özal Medical Center based study

Deniz Yavuz Baskiran, Olcay Murat Disli, Sezai Yilmaz.




Abstract

Venous thromboembolism (VTE) is an important complication observed in patients with chronic liver diseases. This study aims to present demographics and some clinical characteristics of patients with chronic liver disease (CLD) with an emphasis on the development of venous thromboembolism. The study was conducted with the data of patients having chronic liver disease who were admitted to Inonu University Turgut Özal Medical Center Liver Transplant Institute. 63 patients diagnosed with chronic liver diseases were included in the study. Chronic liver disease patients were confirmed according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Positive Doppler ultrasonography, computed tomography, or angiographic study documentation were used to confirm the presence of thrombosis. In conclusion, although patients with CLD are traditionally prone to bleeding disorders, VTE is also a serious complication in these patients. Therefore, it should be considered that anticoagulation treatment should be provided to all CLD patients with verified VTE.

Key words: Venous thromboembolism, chronic liver disease, liver transplant






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.